Cart
Orders
Not available here
Product Overview
Botulax (Botulax Inj.) is a prescription botulinum toxin type A product manufactured by HUGEL, Inc. in South Korea. This TEOSQUARE listing brings together Botulax 100U, 200U and 300U for professional product comparison. Each is presented as a freeze-dried powder in a single-vial box and contains botulinum toxin type A with human serum albumin and sodium chloride. The vial strengths differ in labeled potency and excipient quantities, and their approved indications are not identical. Check the precise strength, destination-market authorization and cold-chain requirements before selecting an option.
Key Features
- Three Labeled Strengths. Botulax 100U, 200U and 300U are distinct vial presentations. Each label identifies the product-specific potency per vial, not a recommended administration amount.
- Manufactured by HUGEL. Botulax is a South Korean botulinum toxin type A medicine manufactured by HUGEL, Inc.
- Freeze-Dried Vial Presentation. The reviewed Korean product records describe white lyophilized powder in a glass vial, with one vial per box for each listed strength.
- Strength-Specific Excipients. Published product information identifies human serum albumin and sodium chloride, with quantities corresponding to the labeled vial strength.
- Market-Specific Authorization. The approved indications for Botulax 300U differ from those of 100U and 200U in the referenced Korean prescribing information. Product authorization must be checked by strength and country.
Composition & Specifications
| Specification | Details |
|---|---|
| Product Family | Botulax (Botulax Inj.; 보툴렉스주) |
| Product Category | Prescription botulinum toxin type A injectable medicine |
| Active Ingredient | Clostridium botulinum toxin type A |
| Manufacturer | HUGEL, Inc. |
| Country of Origin | Republic of Korea |
| Available Strengths Covered | 100 Units, 200 Units and 300 Units per vial |
| Dosage Form | White lyophilized powder in a glass vial |
| Excipients | Human serum albumin and sodium chloride |
| Pack Configuration | One vial per box in the referenced Korean product records |
| Unopened Storage | Refrigerated at 2–8°C in a sealed container |
| ATC Classification | M03AX01 — Botulinum toxin |
These specifications describe the Korean presentations referenced in the source materials. Confirm the original packaging, product information and current authorization for the specific strength and destination market. Botulax potency Units cannot be directly converted to those of other botulinum toxin products.
How Botulax Works
Botulinum toxin type A acts at peripheral cholinergic nerve endings by inhibiting the release of acetylcholine, a neurotransmitter involved in signaling between nerves and muscles. This mechanism produces a temporary reduction in the activity of affected muscles. The clinical application of this pharmacological effect depends on the specific medicine and its approved indications.
Botulax is documented in both therapeutic and aesthetic contexts. However, individual vial strengths do not necessarily have identical authorized indications. A higher labeled unit count does not establish superior efficacy, longer treatment duration or interchangeability with another strength.
The biological potency Units of botulinum toxin products are product-specific and cannot be directly exchanged with the Units of formulations made by other manufacturers.
Compare Botulax 100U, 200U & 300U
Compare the vial strengths and published excipient quantities below to identify the correct Botulax product presentation. The table describes product specifications, not recommended doses or interchangeable treatment options. Korean authorizations differ by strength.
| Product | Labeled Strength | Human Serum Albumin | Sodium Chloride | Packaging |
|---|---|---|---|---|
| Botulax 100 Units | 100 U/vial | 0.5 mg/vial | 0.9 mg/vial | 1 vial/box |
| Botulax 200 Units | 200 U/vial | 1.0 mg/vial | 1.8 mg/vial | 1 vial/box |
| Botulax 300 Units | 300 U/vial | 1.5 mg/vial | 2.7 mg/vial | 1 vial/box |
Excipient quantities reflect the published specifications referenced for this product family and should be checked against the current manufacturer-issued labeling. In the referenced Korean prescribing information, Botulax 300U has specified spasticity-related therapeutic indications. Do not assume that 100U, 200U and 300U have identical approved aesthetic indications.
Professional Product Selection Considerations
When selecting a Botulax option, professional purchasers should match the required labeled vial strength to the actual product carton and the approved indications for the destination market. The 100U, 200U and 300U presentations should not be treated as interchangeable merely because they share an active ingredient.
- Confirm Vial Strength. Identify 100U, 200U or 300U on the original carton. These are product-specific potency Units, not recommended administration quantities.
- Verify Regulatory Scope. Korean labeling for Botulax 300U lists specified spasticity-related indications and differs from the labeling for 100U and 200U. Authorization must be checked for each strength and country.
- Check Pack Identity. Referenced Korean products contain one freeze-dried vial per box. Confirm the actual product label, supplied presentation, expiry date and batch traceability.
- Plan Refrigerated Logistics. The referenced unopened-product requirement is 2–8°C. Confirm appropriate distribution and storage conditions before ordering.
Storage & Handling
The referenced Korean labels specify refrigerated storage of unopened Botulax vials at 2–8°C in a sealed container. Verify the strength, carton identification, batch number, expiration date and market-specific label before procurement or distribution. Maintain applicable cold-chain conditions throughout handling and transport.
Botulax is a prescription medicine intended for administration by appropriately qualified healthcare professionals. Review the current product-specific prescribing information, contraindications and safety warnings before professional use.
Botulinum toxin products may cause serious adverse effects, including effects associated with toxin spread beyond the intended area. Do not use an expired vial or a product with compromised packaging. Preparation, administration and dosing must follow the applicable prescribing information; no procedural instructions are provided on this page.
Frequently Asked Questions
What is the difference between Botulax 100U, 200U and 300U?
Botulax 100U, 200U and 300U contain different product-specific potency Units per vial. Their published human serum albumin and sodium chloride quantities also differ. Importantly, the referenced Korean prescribing information does not provide identical approved indications for all three strengths.
Who manufactures Botulax?
Botulax is manufactured by HUGEL, Inc., a South Korean pharmaceutical and medical aesthetics company. HUGEL identifies Botulax in its official product portfolio.
What ingredients are listed for Botulax?
The active ingredient is Clostridium botulinum toxin type A. The listed excipients are human serum albumin and sodium chloride, with amounts that vary according to the labeled vial strength.
How should unopened Botulax vials be stored?
The referenced Korean product information specifies storage at 2–8°C in a sealed container for the 100U, 200U and 300U presentations. The actual product label and destination-market requirements should be followed.
Does Botulax 300U have the same approved cosmetic indications as Botulax 100U?
Not in the referenced Korean prescribing information. Botulax 300U lists certain spasticity-related therapeutic indications, while the 100U and 200U product information also includes specified facial-wrinkle indications. Confirm the current authorization for each strength and market.
Are Botulax Units interchangeable with Botox or other botulinum toxin brands?
No. Botulinum toxin potency Units are specific to each product and its biological testing method. A numerical Unit value from Botulax must not be treated as directly equivalent to that of another manufacturer's formulation.